Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2006 pubmed

Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats.

Thompson. Emily L EL; Murphy. Kevin G KG; Patterson. Michael M; Bewick. Gavin A GA; Stamp. Gordon W H GW; Curtis. Annette E AE; Cooke. Jennifer H JH; Jethwa. Preeti H PH; Todd. Jeannie F JF; Ghatei. Mohammad A MA; Bloom. Stephen R SR

Key Findings

  • Acute subcutaneous kisspeptin-54 (and shorter peptides) spikes LH and testosterone within an hour.
  • Continuous daily dosing (50 nmol/day for 13 days) reduces testis size, damages seminiferous tubules, and lowers inhibin B in male rats.
  • The hormonal boost disappears after 2 days of nonstop administration, indicating rapid down‑regulation of the HPG axis.

Practical Outcomes

  • For self‑experimenters, short bursts of kisspeptin might temporarily raise testosterone, but daily or longer‑term dosing appears harmful to testicular health in rats. Caution is advised against chronic peripheral kisspeptin use for boosting male hormones, and any human trials should start with very low, intermittent doses and monitor reproductive markers closely.

Summary

Giving kisspeptin-54 under the skin every day for a couple of weeks shrank rat testes and hurt sperm production, even though a single dose briefly raised testosterone. The hormone's boost fades quickly with continuous use, and long‑term dosing may actually suppress the reproductive system.

Abstract

The kisspeptins are KiSS-1 gene-derived peptides that signal through the G protein-coupled receptor-54 (GPR54) and have recently been shown to be critical regulators of reproduction. Acute intracerebroventricular or peripheral administration of kisspeptin stimulates the hypothalamic-pituitary-gonadal (HPG) axis. This effect is thought to be mediated via the hypothalamic gonadotropin-releasing hormone (GnRH) system. Chronic administration of GnRH agonists paradoxically suppresses the HPG axis after an initial agonistic stimulation. We investigated the effects of continuous peripheral kisspeptin administration in male rats by use of Alzet minipumps. Initially we compared the effects of acute subcutaneous administration of kisspeptin-10, -14, and -54 on the HPG axis. Kisspeptin-54 produced the greatest increase in plasma LH and total testosterone at 60 min postinjection and was used in the subsequent continuous administration experiments. Chronic subcutaneous long-term administration of 50 nmol kisspeptin-54/day for 13 days decreased testicular weight. Histological examination showed degeneration of the seminiferous tubules associated with a significant decrease in the circulating levels of the testes-derived hormone, inhibin B. Plasma free and total testosterone were also lower, although these changes did not reach statistical significance. Further studies examined the effects of shorter periods of continuous kisspeptin administration. Subcutaneous administration of 50 nmol kisspeptin-54 for 1 day increased plasma LH and testosterone. This effect was lost after 2 days of administration, suggesting a downregulation of the HPG axis response to kisspeptin following continuous administration. These findings indicate that kisspeptin may provide a novel tool for the manipulation of the HPG axis and spermatogenesis.

Study Information

Provider

pubmed

Year

2006

Date

2006-06-20T00:00:00.000Z

DOI

10.1152/ajpendo.00040.2006